Topic
lupus nephritis
1 stories related to this topic, newest first.
Adrian McArdle, M.B, B.Ch., Kshemendra Senarath-Yapa, M.B.B.Chir., Graham G. Walmsley, B.S., Michael Hu, M.D., M.P.H., David A. Atashroo, M.D.,Ruth Tevlin, M.B., B.Ch.,Elizabeth Zielins, M.D.,Geoffrey C. Gurtner, M.D., Derrick C. Wan, M.D., and Michael T. Longaker, M.D., F.A.C.S. / Wikimedia (CC BY-SA 4.0)finance84 days ago
Nkarta Receives Approval for Outpatient Dosing in Lupus Nephritis Trial
Nkarta announced that regulators have approved a protocol change allowing outpatient dosing of its NKX019 therapy in lupus nephritis trials, reducing patient monitoring time to two hours. Following this update, Nkarta's stock price increased by approximately 13%.